Cohance Lifesciences Ltd vs Makers Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 480.95 as of 06 May 15:30 . The P/E Ratio of Cohance Lifesciences Ltd changed from 34.8 on March 2021 to 110.3 on March 2025 . This represents a CAGR of 25.95% over 5 yearsThe P/E Ratio of Makers Laboratories Ltd changed from 18 on March 2022 to 10.2 on March 2025 . This represents a CAGR of -13.24% over 4 years The Market Cap of Cohance Lifesciences Ltd changed from ₹ 12611 crore on March 2021 to ₹ 29524 crore on March 2025 . This represents a CAGR of 18.55% over 5 yearsThe Market Cap of Makers Laboratories Ltd changed from ₹ 117.71 crore on March 2021 to ₹ 76.11 crore on March 2025 . This represents a CAGR of -8.35% over 5 years The revenue of Cohance Lifesciences Ltd for the Dec '25 is ₹ 550.71 crore as compare to the Sep '25 revenue of ₹ 571.17 crore. This represent the decline of -3.58% The revenue of Makers Laboratories Ltd for the Dec '25 is ₹ 35.99 crore as compare to the Sep '25 revenue of ₹ 34.53 crore. This represent the growth of 4.23% The ebitda of Cohance Lifesciences Ltd for the Dec '25 is ₹ 96.65 crore as compare to the Sep '25 ebitda of ₹ 136.55 crore. This represent the decline of -29.22% The ebitda of Makers Laboratories Ltd for the Dec '25 is ₹ 4.49 crore as compare to the Sep '25 ebitda of ₹ 2.64 crore. This represent the growth of 70.08% The net profit of Cohance Lifesciences Ltd changed from ₹ 75.37 crore to ₹ 29.02 crore over 7 quarters. This represents a CAGR of -42.04% The net profit of Makers Laboratories Ltd changed from ₹ -0.7 crore to ₹ 2.27 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Cohance Lifesciences Ltd changed from 16.5 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Makers Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Cohance Lifesciences Ltd

Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated on November 6, 2018.
The name of the Company has been changed to Cohance Lifesciences Limited w.e.f.
May 7, 2025.
Cohance Lifesciences Ltd is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

About Makers Laboratories Ltd

Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984.
The Company was promoted by Satish Kumar Gupta and Naval Tated.
The Company is presently in manufacture of pharmaceutical formulations and drug intermediates. Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993.
As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL. During 1996-97, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit.

FAQs for the comparison of Cohance Lifesciences Ltd and Makers Laboratories Ltd

Which company has a larger market capitalization, Cohance Lifesciences Ltd or Makers Laboratories Ltd?

Market cap of Cohance Lifesciences Ltd is 18,399 Cr while Market cap of Makers Laboratories Ltd is 89 Cr

What are the key factors driving the stock performance of Cohance Lifesciences Ltd and Makers Laboratories Ltd?

The stock performance of Cohance Lifesciences Ltd and Makers Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cohance Lifesciences Ltd and Makers Laboratories Ltd?

As of May 6, 2026, the Cohance Lifesciences Ltd stock price is INR ₹480.95. On the other hand, Makers Laboratories Ltd stock price is INR ₹151.45.

How do dividend payouts of Cohance Lifesciences Ltd and Makers Laboratories Ltd compare?

To compare the dividend payouts of Cohance Lifesciences Ltd and Makers Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.